Bruker Corp

We believe free cash flow is a useful measure to evaluate our business because it indicates the amount of cash generated after additions to property, plant, and equipment that is available for, among other things, acquisitions, investments in our business, repayment of debt and return of capital to shareholders.

SEC original ↗Bruker Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Specifically, the ASU provides improvements in the following five areas: (i) similar risk assessment of cash flow hedges, (ii) hedging forecasted interest payments on chose-your-rate debt instruments, (iii) cash flow hedges of nonfinancial forecasted transactions, (iv) net written options as hedging instruments, and (v) foreign currency-denominated debt instruments as a hedging instrument and hedged item.

SEC original ↗Bruker Corp — 10-Q Quarterly report10-QAug 5, 2026

” He continued, “Bruker today is announcing a significantly expanded cost management initiative, expected to reduce our annual costs by $100 - $120 million in FY 2026.

SEC original ↗Bruker Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

This supports our commitment to resume rapid margin expansion and double-digit EPS growth next year, even in a scenario where demand remains muted.

SEC original ↗Bruker Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

The segment focuses on metallic low temperature superconductors for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research, and other applications.

SEC original ↗Bruker Corp — 10-Q Quarterly report10-QAug 5, 2026

16 Table of Contents (b) Adjustments and reconciling items consist of costs related to restructuring actions; acquisition and related integration expenses; amortization of acquired intangible assets; costs associated with the Company's global information technology ( IT ) transition initiatives; goodwill, intangible assets, other long-lived asset impairment charges; and other costs.

SEC original ↗Bruker Corp — 10-Q Quarterly report10-QAug 5, 2026

Tariffs and a stiff currency headwind could not yet be compensated for by our mitigating price, supply chain and cost actions in the second quarter.

SEC original ↗Bruker Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

We are lowering our financial guidance for FY 2025, while we gain improved visibility into US academic funding trends, China stimulus, finalized tariffs, as well as into the timing of a recovery in biopharma drug discovery and industrial research instruments demand.

SEC original ↗Bruker Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Additionally, the Company will continue to monitor circumstances and uncertainties that may impact the carrying values of its reporting units, including the current macroeconomic conditions and the timing and quantity of future cash flows.

SEC original ↗Bruker Corp — 10-Q Quarterly report10-QAug 5, 2026